Orthofix International | OFIX - 流动负债



金融业
股票价格
USD
资产
USD 873.02M
现金及等价物
USD 103.81M
销售成本
USD 66.63M
流动资产
USD 446.13M
流动负债
USD 157.01M
债务
USD 137.24M
股息收益率
0
EBIT
USD 6.12M
EBITDA
USD 27.88M
员工
1.09K
EPS每股收益
USD 0.09
股本和储备
USD 429.18M
销售毛利
USD 153.28M
债务利息支出
4.68M
贷款资金
USD 221.59M
市值
USD 370.7M
净收入
USD -2.22M
营业费用
USD 213.79M
营业利润
USD 6.12M
普通股股本
USD 39.83M
PE价格收益
4.17K
税前利润
USD -2.19M
销售收入
USD 219.91M
销售和管理费用
USD 130.35M
股票
USD 184.48M
贸易债权人
USD 63.53M
应收帐款人
USD 135.75M


流动负债 更改 日
Accuray USD 199.44M 4.83M 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 106.93M 14.23M 2026-06
AtriCure USD 81.92M 8.72M 2026-06
Dexcom USD 2.36B 133.9M 2026-06
EDAP TMS EUR 37.51M 6.1M 2026-03
Globus Medical USD 479.35M 3.12M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
J&J USD 54.9B 2.82B 2026-06
Medtronic USD 9.5B 440M 2025-12
Mesa Laboratories USD 54.4M 6.1M 2025-12
Orthofix International USD 157.01M 4.02M 2026-06
Plus Therapeutics USD 8.57M 612K 2026-06
Smith & Nephew USD 2.05B 510M 2026-06
STAAR Surgical USD 73.39M 12.4M 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
Veracyte USD 62.74M 6.62M 2026-06
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06